Latest News
Stocks struggled for direction amid tariff jitters ahead of the Wednesday deadline.
Via Talk Markets · March 31, 2025
Detroit automakers are attempting to reassure their employees and investors as they work to mitigate challenges posed by President Donald Trump's sweeping 25% tariffs on imported vehicles and auto parts set to go into effect on Thursday.
Via Benzinga · March 31, 2025
Via Benzinga · March 31, 2025
Via Benzinga · March 31, 2025
Via Benzinga · March 31, 2025
March 31, 2025 – In the ever-evolving world of retail investing, Reddit has emerged as a powerful hub for stock market enthusiasts to share ideas, debate strategies, and rally behind their favorite companies. From the infamous GameStop (GME) saga of 2021 to more recent darlings, the platform’s communities—particularly subreddits
Via MarketMinute · March 31, 2025
Via Benzinga · March 31, 2025
Via Benzinga · March 31, 2025
Via Benzinga · March 31, 2025
As of 4:00 PM EDT on March 31, 2025, Roku, Inc. (NASDAQ: ROKU) shares are experiencing a noticeable decline, dropping 2.91% to close at $70.44. This downturn follows a trading session where the stock oscillated between a low of $67.50 and a high of $71.24,
Via MarketMinute · March 31, 2025
Via Benzinga · March 31, 2025
President Trump's tariff announcement is just one day after eurozone inflation numbers are released.
Via Talk Markets · March 31, 2025
Intel is currently working on a lower-powered 18AP node, which may prove attractive for Nvidia.
Via Talk Markets · March 31, 2025
Via Benzinga · March 31, 2025
Tesla investors have been on a rollercoaster ride in recent months.
Via Talk Markets · March 31, 2025
Shares of energy drink company Celsius (NASDAQ:CELH)
jumped 8.9% in the afternoon session after Truist analysts upgraded the stock's rating from Hold to Buy and raised the price target from $35 to $45. The analysts added, "In our opinion, the market is already looking past the hiccups of the legacy business in 2024 and the brand's slowdown in 1Q25."
Via StockStory · March 31, 2025
Shares of biotechnology company Moderna (NASDAQ:MRNA)
fell 12.5% in the morning session after Peter Marks, the head of the FDA's Center for Biologics Evaluation and Research (CBER), resigned on Friday, 28 March 2025. Marks noted his departure was related to "misinformation and lies" around immunization and raised concerns about the Trump administration's ability to "swiftly approve critical vaccines."
Via StockStory · March 31, 2025
Users' AI prompts will likely tap into one of CoreWeave's data centers. The company's future relies on this explosive growth.
Via Talk Markets · March 31, 2025
Via Benzinga · March 31, 2025
Via Benzinga · March 31, 2025